CSCO
58
-2
R
70
-3
ADP
65
-3
GLW
45
-3
REGN
38
-2
ILMN
32
-9
SYF
86
-6
GD
41
-4
MAS
52
-4
URI
60
-6
MS
77
-2
BDX
56
10
VRTX
47
-6
IRM
41
3
MTCH
20
-8
TJX
62
-2
ECL
55
-2
AIV
64
4
EL
15
-3
CHD
54
4
CSCO
58
-2
R
70
-3
ADP
65
-3
GLW
45
-3
REGN
38
-2
ILMN
32
-9
SYF
86
-6
GD
41
-4
MAS
52
-4
URI
60
-6
MS
77
-2
BDX
56
10
VRTX
47
-6
IRM
41
3
MTCH
20
-8
TJX
62
-2
ECL
55
-2
AIV
64
4
EL
15
-3
CHD
54
4
Financhill
Back

Atlas Copco AB Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
37

ATLCY
Atlas Copco AB

Last Price:
13.87
Seasonality Move:
3.99%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
37
Atlas Copco AB (ATLCY) is a Sell

Is Atlas Copco AB a Buy, Sell or Hold?

  • The current Atlas Copco AB [ATLCY] share price is $13.87. The Score for ATLCY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • ATLCY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ATLCY Stock Price Chart

What is Atlas Copco AB's stock price today?

  • The Atlas Copco AB share price today is $13.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATLCY is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

ATLCY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 32.09 Sell
Chaikin Money Flow: -29673 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.25 - 15.65) Sell
Bollinger Bands (100): (14.78 - 16.3) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

ATLCY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.37 Sell
20-day SMA: 14.67 Sell
50-day SMA: 15.53 Sell
200-day SMA: 15.5 Sell
8-day EMA: 14.27 Sell
20-day EMA: 14.71 Sell
50-day EMA: 15.24 Sell
200-day EMA: 15.13 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Atlas Copco AB Earnings Growth & ATLCY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Atlas Copco AB Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):